The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Sebastian Steven(Goethe University Frankfurt), Andreas Daiber(Johannes Gutenberg University Mainz)
Cited by 303
Related Papers
Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions
|European Heart Journal|2019|890
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
|Oxidative Medicine and Cellular Longevity|2019|696
Transportation noise pollution and cardiovascular disease
|Nature Reviews Cardiology|2021|544
Environmental Noise and the Cardiovascular System
|Journal of the American College of Cardiology|2018|506